These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 918004)

  • 1. [Prognosis of grippe in 1977-1978].
    Munzinger J
    Schweiz Rundsch Med Prax; 1977 Oct; 66(43):1357-8. PubMed ID: 918004
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of osteopathic manipulative treatment on immune response to the influenza vaccine in nursing homes residents: a pilot study.
    Noll DR; Degenhardt BF; Stuart MK; Werden S; McGovern RJ; Johnson JC
    Altern Ther Health Med; 2004; 10(4):74-6. PubMed ID: 15285277
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vaccination of a group of young people with influenza virus A/New Jersey/ 1976 (Hsw 1 N 1)].
    Masurel N; de Jong P; Verhoeff WF
    Ned Tijdschr Geneeskd; 1977 Nov; 121(45):1794-800. PubMed ID: 927558
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
    Bruj J; Skocil V; Farník J; Hronovský F; Síp J
    Cesk Epidemiol Mikrobiol Imunol; 1981 Sep; 30(5):287-93. PubMed ID: 6456837
    [No Abstract]   [Full Text] [Related]  

  • 5. [Low protection against this winter's influenza. A repeat performance of last season's subtype A?].
    Grandien M; Nordén A; Jonson G
    Lakartidningen; 1992 Dec; 89(50):4374. PubMed ID: 1469973
    [No Abstract]   [Full Text] [Related]  

  • 6. Influenza pandemics, immune cross-reactivity, and pandemic control strategies.
    Gioia C; Agrati C; Castilletti C; Capobianchi MR; Martini F
    J Infect Dis; 2008 Jul; 198(2):294-5; author reply 295-6. PubMed ID: 18593297
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiologic surveillance of influenza or grippe and other acute respiratory infections in Cuba].
    González Ochoa E; Goyenechea Hernández A; Armas Pérez L; López Prats E; Pérez Rodríguez A; Oropesa Fernández S; Savón Valdéz C; Bello Conedor M; Díaz Rosa O; Pérez Guevara MT
    Rev Cubana Med Trop; 1988; 40(2):119-37. PubMed ID: 3067276
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative studies in influenza vaccines].
    Kunz C; Wiedermann G; Dostal V
    Wien Med Wochenschr; 1975 Oct; 125(40):581-2. PubMed ID: 1226778
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of vaccination against influenza A in troop collectives].
    Khokhlov DT; Degtiarev AA; Furgal SM
    Voen Med Zh; 1987 Dec; (12):38-9. PubMed ID: 3441998
    [No Abstract]   [Full Text] [Related]  

  • 11. [The current influenza-grippe situation. Consequences for general practice].
    Werner J; Kuwert E
    MMW Munch Med Wochenschr; 1979 Oct; 121(43):1403-5. PubMed ID: 119906
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 13. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis].
    Mukhina LP; Bichurina MA; Rozaeva NR
    Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508
    [No Abstract]   [Full Text] [Related]  

  • 14. Canadian influenza serosurvey prior to the 1992-1993 season.
    Can Commun Dis Rep; 1992 Nov; 18(22):161-6. PubMed ID: 1291010
    [No Abstract]   [Full Text] [Related]  

  • 15. Influenza.
    Sabin AB
    Dev Biol Stand; 1976; 33():127-40. PubMed ID: 955265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057
    [No Abstract]   [Full Text] [Related]  

  • 17. The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
    Khanlou H; Sanchez S; Babaie M; Chien C; Hamwi G; Ricaurte JC; Stein T; Bhatti L; Denouden P; Farthing C
    Arch Intern Med; 2006 Jul; 166(13):1417. PubMed ID: 16832008
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative anti-influenza vaccination of some groups of the population with vaccines differing in virus purification level.
    Brydak L; Gall W; Semkow R
    Arch Immunol Ther Exp (Warsz); 1987; 35(2):201-6. PubMed ID: 3447535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase antibodies and H5N1: geographic-dependent influenza epidemiology could determine cross-protection against emerging strains.
    Bermejo-Martin JF; Kelvin DJ; Guan Y; Chen H; Perez-Breña P; Casas I; Arranz E; de Lejarazu RO
    PLoS Med; 2007 Jun; 4(6):e212. PubMed ID: 17593897
    [No Abstract]   [Full Text] [Related]  

  • 20. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.